While this could fit with our hypothesis of reduced CD8+ T-cells and increased Tregs impacting on anti-tumour immunity, Tregs are only a small, albeit potent, sub-population of predominantly CD4+ T-cells in CRC. The gene discussed is CD4; the disease is colorectal carcinoma.